Biomarker evaluation for prognostic stratification of patients with COVID-19: the added value of quantitative chest CT

Aim: Pulmonary disease burden and biomarkers are possible predictors of outcomes in patients with COVID-19 and provide complementary information. In this study, the prognostic value of adding quantitative chest computed tomography (CT) to a multiple biomarker approach was evaluated among 148 hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Roberto M, de Oliveira, Gabriel SS, da Rocha, João RF, de MC Ribeiro, Felipe, Stern, João J, de S Costa, Rangel, Lemgruber, Ricardo N, Ramalho, Júlia FP, de Almeida, Alexandre CP, Sampaio, Pedro PN, Filho, João Mansur, Lima, Ricardo AC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855956/
https://www.ncbi.nlm.nih.gov/pubmed/35176874
http://dx.doi.org/10.2217/bmm-2021-0536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855956/
https://www.ncbi.nlm.nih.gov/pubmed/35176874
http://dx.doi.org/10.2217/bmm-2021-0536

Ejemplares similares